Thrombolex, Inc., a commercial-stage developer of a differentiated pharmacomechanical lysis platform for the treatment of pulmona ...
These presentations build upon momentum from E2's late-breaking presentation at VIVA 2025 in Las Vegas, which introduced initial ENGULF pivotal cohort outcomes. Each presentation showcases distinct, ...
Perfuze, an Ireland-based developer of catheters for interventional stroke care, announced it has received FDA 510(k) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results